Dublin, Sept. 25, 2024 (GLOBE NEWSWIRE) -- The "Autoinjectors Market Industry Trends and Global Forecasts to 2035: Distribution by Usability, Route of Administration, Type of Molecule Delivered, Volume of Container, Type of Actuation Mechanism, End-user, Target Indication and Key Geographical Regions" report has been added to ResearchAndMarkets.com's offering.
The Global Autoinjector Market is valued at USD 90.6 billion in 2024 growing at a CAGR of 6.2% during the forecast period 2024-2035.
Autoinjectors are self-injection devices inbuilt to deliver a specific dose of a drug / therapeutic substance with a simple push of a button. They are spring-loaded syringes working on several mechanisms (ranging from simple push-on-skin devices to fully automated button activated technologies) and include pre-measured medication, thereby, eliminating the need to draw medication from a separate vial, thus resolving various injection-related compliance issues faced by the patients.
The Global Autoinjectors Market is driven by a growing demand for self-administration devices largely due to the increasing chronic conditions such as asthma, diabetes, multiple sclerosis and rheumatoid arthritis. Moreover, these conditions have also been adding to the increasing healthcare burden. A study conducted in the year 2022 reveals that there are around 133 million individuals suffering from one or more chronic illness within the US alone, wherein the predicted value by 2030, is 177 million. The market insights reveal that the treatment of chronic diseases in the hospitals involves intensive care and costs more than USD 1.50 trillion per year with additional expenses throughout an individual's lifetime.
The frequent need to take the medication, necessitating regular hospital visits, contributes to the major share of the expenses incurred by patients suffering from chronic diseases. In addition, the reluctance of individuals to receive injections in a clinical setting due to privacy concerns and discomfort complements the challenges for healthcare providers, compromising the treatment process.
Hence, the above-mentioned challenges are addressed by various self-administering drug delivery systems, such as prefilled syringes, large volume wearable injectors, needle free jet injectors, turning out to be a breakthrough. These drug delivery devices impart greater independence, eliminating the dependence on healthcare providers for drug administration, leading to reduced healthcare costs. However, these drug delivery systems possess certain limitations, such as skin sensitivity issues, manual needle insertion, and needle stick injuries, thereby creating the need for better administration solutions.
Because of the insufficiency of the conventional drug delivery systems, the rapid gaining performance of autoinjectors is worth noticing, specifically in the immediate treatment of emergency situations, such as anaphylactic shocks, strokes and rheumatoid arthritis. In addition, the audio-visual features in some of the autoinjectors allow the patient to remove the device from the skin, on completion of dose. The growing adoption of self-administration devices and ongoing advancements in the technologies (focused on integrated needle safety, Bluetooth connectivity and monitoring of historical injection logs), tends to create a growing market of Autoinjectors henceforth.
Research Coverage:
- An overview of various self-administrable devices for drug delivery, specifically focusing on autoinjectors. The report provides information on the progression of autoinjectors, along with related details such as, their individual components, device categories and associated manufacturing / packaging processes. It also discusses the advantages of autoinjectors that have led to their growing adoption over the last several years along with the existing concerns related to needlestick injuries and the various preventive laws that have been passed worldwide, for addressing the pressing need for introducing advanced safety features in such devices. In addition, it also includes a discussion on the prospects of this industry.
- The report also discusses about the various types of primary drug containers that are utilized in autoinjectors. It demonstrates information on current trends related to the use of prefilled syringes, cartridges and vials. In addition, enlistment the diverse types of primary drug containers that are available in the market, along with details on companies that are involved in the production of such containers is also included in the chapter.
- A thorough analysis of current market landscape of autoinjectors based on several relevant parameters, such as status of development, usability, type of primary drug container, requirement of needle, volume of container, type of dose delivered, route of administration, type of actuation mechanism, type of feedback mechanism, availability of connectivity feature, target indication, type of molecule delivered and end user.
- The report includes a detailed biopsy of the leading autoinjector manufacturers, highlighting the current perceptions regarding their proprietary brands across different device types. It takes into consideration several aspects, such as strength and diversity of product portfolio, routes of administration, type of actuation mechanism, type of feedback mechanism, geographical presence / reach and supplier strength of each player.
- A comprehensive profile of key autoinjector manufacturers
- An in-depth analysis of the partnerships inked between stakeholders engaged in this industry, during the period 2019-2023.
- A detailed exploration of patents related to autoinjectors, filed / granted, since 2019, based on the type of patent, patent publication year, patent application year, patent jurisdiction, cooperative patent classification (CPC) symbols, type of applicant and most active players.
- Current market landscape of commercialized autoinjectors combination product, such as approval year, usability, type of primary drug container, requirement of needle, volume of container, injection time, type of dose delivered, route of administration, type of actuation mechanism, type of feedback mechanism, availability of connectivity feature, target indication, severity of indication, type of molecule delivered, end user and target population.
- Detailed progression of the current market landscape of early and late stage autoinjectors combination product, such as stage of development, route of administration, dose strength, target indication, severity of indication, type of molecule delivered, end user, target population and gender of target population.
- Comprehensive set of profiles of the key players that are engaged in the autoinjector combination products domain. Each profile provides an insight of the company and information on its autoinjector product portfolio.
- A detailed analyzed evaluation highlighting the key opinion leaders (KOLs) in this domain
- A case study converged on the role of medical device CMOs in the manufacturing and assembly of drug-delivery devices, including autoinjectors. It enlists service providers with details on their operational scale and types of services provided for device production.
- An intricate case history of prefilled syringes that either fall into the category of commercialized or under development. It includes an itemized description of the prefilled syringes, based on several relevant dynamics, such as, type of barrel fabrication material, number of barrel chambers and type of needle system. Further, the chapter provides a detailed analysis of prefilled syringe manufacturers, along with information on their year of establishment, company size and location of headquarters.
- A projection of the current and future opportunity within the autoinjectors market across usability, such as disposable autoinjectors and reusable autoinjector.
- Detailed projections of the current and future opportunity within the auto injector market size across several types of dynamics, which include route of administration, such as intramuscular, intravenous and subcutaneous, the type of molecule, such as antibodies, peptides, proteins, small molecules and others, type of actuation mechanism, such as manual and automatic, volume of container, such as less than 1 mL, 1-2 mL and more than 2 mL, various end user, such as ambulatory surgical centers, home care and hospitals and clinics.
- An in-depth insightful projection of the current and future opportunity within the autoinjector market across target indication, such as anaphylaxis, diabetes, migraine, multiple sclerosis, rheumatoid arthritis, weight loss and other indications.
Leading Market Companies
- Amgen
- Antares Pharma
- ChemProtect.SK
- Elcam Medical
- Eli Lilly and Company
- Jiangsu Delfu Medical Device
- Kindeva Drug Delivery
- Merck
- Novartis
- Novo Nordisk
- Oval Medical Technologies
- Owen Mumford
- PreciHealth
- Recipharm
- Sanofi
- SHL Medical
- Teva Pharmaceuticals
- Union Medico
- Ypsomed
Key Topics Covered:
1. PREFACE
2. RESEARCH METHODOLOGY
3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
4. EXECUTIVE SUMMARY
5. INTRODUCTION
5.1. Chapter Overview
5.2. Types of Drug Delivery Systems
5.3. Drawbacks of Conventional Parenteral Delivery Systems
5.4. Emerging Trend of Self-Administration
5.4.1. Rising Burden of Chronic Diseases
5.4.2. Healthcare Cost Savings
5.4.3. Need for Immediate Treatment in Emergency Situations
5.4.4. Growth of Injectable Biologics Market
5.4.5. Addressing Key User Safety Requirements
5.5. Types of Self-Administration Devices
5.5.1. Prefilled Syringes
5.5.2. Pen-Injectors
5.5.3. Needle-Free Injectors
5.5.4. Large Volume Wearable Injectors
5.5.5. Autoinjectors
5.6. Overview of Autoinjectors
5.6.1. Components of Autoinjectors
5.6.2. Classification of Autoinjectors
5.6.3. Manufacturing / Packaging of Autoinjectors
5.6.4. Benefits of Autoinjectors
5.7. Regulatory Considerations
5.8. Future Perspectives
6. PRIMARY DRUG CONTAINERS USED IN AUTOINJECTORS
6.1. Chapter Overview
6.2. Types of Packaging
6.3. Primary Drug Containers
6.4. Comparison of Different Fabrication Materials
7. AUTOINJECTORS: MARKET OVERVIEW
7.1. Chapter Overview
7.2. Autoinjectors: Overall Market Landscape
7.3. Autoinjector Manufacturers: Overall Market Landscape
8. PRODUCT COMPETITIVENESS ANALYSIS
8.1. Chapter Overview
8.2. Assumptions and Key Parameters
8.3. Methodology
8.4. Autoinjectors: Product Competitiveness Analysis
8.4.1. Disposable Autoinjectors
8.4.2. Reusable Autoinjectors
9. BRAND POSITIONING ANALYSIS
9.1. Chapter Overview
9.2. Assumptions and Key Parameters
9.3. Methodology
9.4. Autoinjector Manufacturers: Brand Positioning Framework
9.4.1. Brand Positioning Framework: Owen Mumford
9.4.2. Brand Positioning Framework: Ypsomed
9.4.3. Brand Positioning Framework: Elcam Medical
9.4.4. Brand Positioning Framework: SHL Medical
9.4.5. Brand Positioning Framework: Union Medico
9.4.6. Brand Positioning Framework: Antares Pharma
9.4.7. Brand Positioning Framework: PreciHealth
9.4.8. Brand Positioning Framework: Jiangsu Delfu Medical Device
9.4.9. Brand Positioning Framework: Oval Medical Technologies
9.4.10. Brand Positioning Framework: Recipharm
10. AUTOINJECTOR MANUFACTURERS: DETAILED COMPANY PROFILES
10.1. Chapter Overview
10.2. Antares Pharma
10.3. Elcam Medical
10.4. Jiangsu Delfu Medical Device
10.5. Oval Medical Technologies
10.6. Owen Mumford
10.7. PreciHealth
10.8. Recipharm
10.9. SHL Medical
10.10. Union Medico
10.11. Ypsomed
10.3. Recent Expansion Models
10.4. Emerging Peptide Synthesis Technologies
10.4.1. Chemo-Enzymatic Peptide Synthesis Technology
10.4.2. Continuous Flow Technology
10.4.3. Green Chemistry
11. PARTNERSHIPS AND COLLABORATIONS
11.1. Chapter Overview
11.2. Partnership Models
11.3. Autoinjectors: Partnerships and Collaborations
12. PATENT ANALYSIS
12.1. Chapter Overview
12.2. Scope and Methodology
12.3. Autoinjectors: Patent Analysis
12.4. Patent Benchmarking Analysis
12.5. Patent Valuation
12.6. Leading Patents by Number of Citations
13. DEMAND ANALYSIS DRUG DEVICE COMBINATIONS: COMMERCIALIZED AUTOINJECTORS
13.1. Chapter Overview
13.2. Drug Device Combinations: Commercialized Autoinjectors
13.3. Drug Device Combinations: Commercialized Autoinjector Developers
14. DRUG DEVICE COMBINATIONS: EARLY AND LATE STAGE AUTOINJECTORS
14.1. Chapter Overview
14.2. Drug Device Combinations: Early and Late Stage Autoinjectors
14.3. Drug Device Combinations: Early and Late Stage Autoinjector Developers Landscape
15. SHORT COMPANY PROFILES: AUTOINJECTOR COMBINATION PRODUCT DEVELOPERS
- Amgen
- ChemProtect.SK
- Eli Lilly and Company
- Kindeva Drug Delivery
- Merck
- Novartis
- Novo Nordisk
- Sanofi
- Teva Pharmaceutical Industries
16. KEY OPINION LEADER ANALYSIS
17. CASE STUDY: KEY THERAPEUTIC INDICATIONS
- Anaphylaxis
- Multiple Sclerosis
- Migraine
- Rheumatoid Arthritis
18. CASE STUDY: MEDICAL DEVICE CONTRACT SERVICE PROVIDERS
- Challenges Associated with Medical Device Manufacturing
- Role of CMOs in Medical Device Manufacturing
- Services Offered by Medical Device CMOs
- Advantages Offered by Medical Device CMOs
- Risks Associated with Outsourcing to CMOs
- Drug Delivery Device Service Providers
19. CASE STUDY: PREFILLED SYRINGES
19.1. Chapter Overview
19.2. Prefilled Syringes: Market Landscape
19.2.1. Analysis by Type of Barrel Fabrication Material
19.2.2. Analysis by Number of Barrel Chambers
19.2.3. Analysis by Type of Needle System
19.3. Prefilled Syringes Manufacturers: Overall Market Landscape
19.4. Future Perspectives
20. SWOT ANALYSIS
20.1. Chapter Overview
20.2. Strengths
20.2.1. Ease of Drug Delivery
20.2.2. Ability to Minimize / Eliminate Medication Errors
20.2.3. Enhanced Safety Features
20.2.4. Economic Advantages
20.2.5. Drug Life Cycle Management
20.3. Weaknesses
20.3.1. Manufacturing Complexities
20.3.2. Customized Design for Different Formulations
20.3.3. Use Errors
20.3.4. Stringent Regulatory Guidelines
20.4. Opportunities
20.4.1. Rich and Growing Pipeline of Biologics and Biosimilars
20.4.2. Growing Preference for Self-Injection Devices
20.4.3. Integration of Advanced Technologies
20.4.4. Rising Popularity across the Globe
20.5. Threats
20.5.1. Material Compatibility Issues
20.5.2. Availability of Alternative Drug Delivery Devices
20.5.3. Concern Related to Numerous Product Recalls In Past
21. GLOBAL AUTOINJECTORS MARKET
22. AUTOINJECTORS MARKET, BY USABILITY
23. AUTOINJECTORS MARKET, BY ROUTE OF ADMINISTRATION
24. AUTOINJECTORS MARKET, BY TYPE OF MOLECULE DELIVERED
25. AUTOINJECTORS MARKET, BY TYPE OF ACTUTATION MECHANISM
26. AUTOINJECTORS MARKET, BY VOLUME OF CONTAINER
27. AUTOINJECTORS, BY END-USER
28. AUTOINJECTORS MARKET, BY TARGET INDICATION
29. AUTOINJECTORS, BY KEY GEOGRAPHICAL REGION
30. AUTOINJECTORS MARKET, FOR RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS
31. AUTOINJECTORS MARKET, FOR MULTIPLE SCLEROSIS
32. AUTOINJECTORS MARKET, FOR DIABETES
33. AUTOINJECTORS MARKET, FOR ANAPHYLAXIS
34. AUTOINJECTORS MARKET, FOR WEIGHT LOSS
35. AUTOINJECTORS MARKET, FOR MIGRAINE
36. AUTOINJECTORS MARKET, FOR OTHER INDICATIONS
37. CONCLUDING REMARKS
38. EXECUTIVE INSIGHTS
- Aktiv Pharma
- Rx Bandz
- Kindeva Drug Delivery
- DALI Medical Devices
- Elcam Medical
- Pharma Consult
- IDEO
- Bill & Melinda Gates Foundation
- Oval Medical Technologies
For more information about this report visit https://www.researchandmarkets.com/r/ipi4ua
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
